Harmony Biosciences Holdings (HRMY)
Return on assets (ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 145,493 | 128,853 | 181,468 | 34,597 | -36,944 |
| Total assets | US$ in thousands | 999,200 | 811,448 | 673,870 | 433,443 | 427,074 |
| ROA | 14.56% | 15.88% | 26.93% | 7.98% | -8.65% |
December 31, 2024 calculation
ROA = Net income ÷ Total assets
= $145,493K ÷ $999,200K
= 14.56%
Based on the data provided, Harmony Biosciences Holdings has experienced fluctuations in its return on assets (ROA) over the past five years.
The ROA was negative at -8.65% as of December 31, 2020, indicating that the company was not effectively utilizing its assets to generate profits. However, there was a significant improvement in the following years, with ROA increasing to 7.98% as of December 31, 2021.
The trend of improvement continued with a robust ROA of 26.93% as of December 31, 2022, suggesting that Harmony Biosciences Holdings was able to generate substantial profits relative to its asset base.
Although there was a slight decrease in ROA to 15.88% as of December 31, 2023, and further to 14.56% as of December 31, 2024, the company still maintained a relatively healthy return on assets during these periods.
Overall, the increasing trend in ROA from negative to positive values indicates that Harmony Biosciences Holdings has been able to enhance its operational efficiency and profitability, making better use of its assets to generate earnings over the specified timeframe.
Peer comparison
Dec 31, 2024